Omega Healthcare Investors (NYSE:OHI) recently reached a new 52-week high of $47.94. The company maintains a “Moderate Buy” consensus rating from MarketBeat with a target price of $47.36, and has seen mixed analyst adjustments including a positive “overweight” rating and $52 target from Cantor Fitzgerald. OHI declared a quarterly dividend of $0.67 per share, yielding 5.6%, though its dividend payout ratio is high at 138.86%.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Omega Healthcare Investors (NYSE:OHI) Hits New 52-Week High - Still a Buy?
Omega Healthcare Investors (NYSE:OHI) recently reached a new 52-week high of $47.94. The company maintains a “Moderate Buy” consensus rating from MarketBeat with a target price of $47.36, and has seen mixed analyst adjustments including a positive “overweight” rating and $52 target from Cantor Fitzgerald. OHI declared a quarterly dividend of $0.67 per share, yielding 5.6%, though its dividend payout ratio is high at 138.86%.